$9.20
Price
$15M
Market Cap
—
P/E Ratio
-0.4
Forward P/E
$-8.80
EPS (TTM)
—
Dividend Yield
$16M
Cash
$30M
Total Debt
2M
Shares Out
$2.00
$16.10
52-Week Range
Institutional Ownership of Finch Therapeutics Group Inc
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for Finch Therapeutics Group Inc
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2024-Q1 | |||||
| SELL | EXIT | — | — | $2.70 | |
| 2023-Q2 | |||||
| SELL | EXIT | — | — | $10.74 | |
| BUY | NEW | 67.3K | $574000 | $10.74 | |
| 2023-Q1 | |||||
| BUY | +98.1% | 2.0M | $793000 | — | |
| 2022-Q4 | |||||
| SELL | -9.3% | 1.0M | $489000 | — | |
| 2022-Q1 | |||||
| SELL | -0.8% | 1.1M | $6M | — | |
| 2021-Q4 | |||||
| SELL | -6.3% | 1.1M | $11M | — | |
| 2021-Q1 | |||||
| BUY | NEW | 1.2M | $19M | — | |
Insider Trading for Finch Therapeutics Group Inc
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.